(Q37208374)

18 August 2017

1 reference

title

Towards immunotherapeutic drugs and vaccines against multiple sclerosis (English)

1 reference

18 August 2017

0 references

1 reference

Vasso Apostolopoulos

4

0 references

author name string

Maria Katsara

series ordinal

1

1 reference

18 August 2017

John Matsoukas

series ordinal

2

1 reference

18 August 2017

George Deraos

series ordinal

3

1 reference

18 August 2017

publication date

1 July 2008

1 reference

Acta Biochimica et Biophysica Sinica

18 August 2017

published in

1 reference

18 August 2017

volume

40

1 reference

18 August 2017

issue

7

1 reference

18 August 2017

page(s)

636-642

1 reference

Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7270.2008.00444.X

Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7270.2008.00444.X

Mechanisms of action of glatiramer acetate in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7270.2008.00444.X

Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7270.2008.00444.X

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7270.2008.00444.X

10.1111/J.1745-7270.2008.00444.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference